Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CRRFY | QXO |
|---|---|---|
| Price | $3.54 | $11.88 |
| Change today | ▲ 1.14% | ▼ 1.49% |
| Market cap | $12.35B | $12.33B |
| Return, 3 months | -3.3% | -22.1% |
| Return, year to date | +14.1% | -38.4% |
| Return, 1 year | +24.1% | -39.9% |
| P/E (TTM) | 7.1 | -12.9 |
| P/B | 1.0 | 1.3 |
| P/E percentile vs own 5y | – | 63rd |
| Dividend yield | 6.47% | – |
| Revenue growth (YoY, latest qtr) | – | +70.3% |
| Net profit growth (YoY) | – | +6.8% |
| Gross margin | – | 24.0% |
| Operating margin | – | -3.4% |
| Net margin | – | -6.3% |
| Return on equity | – | -6.8% |
| Analyst target vs. price | – | +153.6% |
| Analyst buy share | – | 100% |
| RSI (14) | 35 | 43 |
| 30-day volatility | 23.3% | 46.4% |
| Max drawdown, 1 year | -11.0% | -58.4% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
